Form 4: H.B. Fuller Executive Heather Campe Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Heather Campe, Sr. VP of International Growth at H.B. Fuller, filed a Form 4 detailing transactions involving company stock and derivative securities.
Summary
- Heather Campe, a Senior Vice President at H.B. Fuller, reported changes in her beneficial ownership of the company's securities.
- The report includes transactions related to common stock, phantom units, employee stock options, and restricted stock units.
- As of April 12, 2024, Campe directly owns 19,738.6822 shares of common stock.
- She also holds various employee stock options with different exercise prices and expiration dates, as well as restricted stock units that vest over time.
- Some of the reported holdings include phantom units that convert into common stock and restricted stock units acquired through dividend equivalent reinvestment.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
This filing is a routine disclosure required by the SEC for corporate insiders and provides transparency regarding their holdings and transactions in the company's securities.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the holdings of a key executive.
- It can influence investor sentiment, although typically Form 4 filings have a limited impact unless they reveal significant buying or selling activity.
Key Dates
| Date | Description |
|---|---|
| 01/26/2018 | Date of employee stock option grant with an exercise price of $50.1 and an expiration date of 01/26/2027. |
| 01/25/2019 | Date of employee stock option grant with an exercise price of $53.57 and an expiration date of 01/25/2028. |
| 01/27/2022 | Date of employee stock option grant with an exercise price of $51.89 and an expiration date of 01/27/2031. |
| 01/24/2023 | Date of employee stock option grant with an exercise price of $72.94 and an expiration date of 01/24/2032, and restricted stock units vesting until 01/24/2025. |
| 01/24/2024 | Date of employee stock option grant with an exercise price of $68.17 and an expiration date of 01/24/2033, and restricted stock units vesting until 01/24/2026. |
| 01/26/2025 | Date of employee stock option grant with an exercise price of $77.72 and an expiration date of 01/26/2034, and restricted stock units vesting until 01/26/2027. |
| 04/12/2024 | Date of the earliest transaction reported. |
| 04/15/2024 | Date of the report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.